Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs

Dongyue Li; Peng Zhan; Huiqing Liu; Christophe Pannecouque; Jan Balzarini; De Clercq Erik; Xinyong Liu

doi:10.1016/j.bmc.2012.12.049

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Boronic acid-containing diarylpyrimidine derivatives as novel HIV-1 NNRTIs: Design, synthesis and biological evaluation

Da Feng, Fenju Wei, Yanying Sun, Prem P. Sharma, Tao Zhang, Hao Lin, Brijesh Rathi, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2017

Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives as potent HIV-1 NNRTIs

Zhaoqiang Liu, Ye Tian, Jinghan Liu, Boshi Huang, Dongwei Kang, De Clercq Erik, Dirk Daelemans, Christophe Pannecouque, Peng Zhan, Xinyong Liu

Article2023

Design, synthesis, and biological evaluation of benzo[4,5]thieno[2,3-d]pyrimidine derivatives as novel HIV-1 NNRTIs

Bairu Meng, Zongji Zhuo, Han Yu, Sining Tao, Zixuan Chen, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2022

Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluation

Da Feng, Hao Lin, Liyang Jiang, Jiaojiao Dai, Xiaoying Zhang, Zhongxia Zhou, Yanying Sun, Zhao Wang, De Clercq Erik, Christophe Pannecouque, Dongwei Kang, Peng Zhan, Xinyong Liu

Article2013

Design, synthesis and biological evaluation of 3-benzyloxy-linked pyrimidinylphenylamine derivatives as potent HIV-1 NNRTIs

Diwakar Rai, Wen‐Ming Chen, Ye Tian, Xuwang Chen, Peng Zhan, De Clercq Erik, Christophe Pannecouque, Jan Balzarini, Xinyong Liu